"Given the fact that there are states, counties, cities, school districts, pension funds, and other plaintiffs from all over ...
Sen. James Lankford has been trying to pass legislation in response to an industry he believes will leave small towns without ...
The industry says it keeps down the cost of prescription drugs, but critics say it's profiting at the expense of patients.
The report shows that PBMs made over $7.3 billion in extra profits from dispensing specialty generic drugs during the study ...
At a public meeting held on January 15, 2025, the Federal Trade Commission (FTC) summarized the Second Interim Staff Report ...
Even as a move to regulate pharmacy benefit managers like Express ... Earlier this month, the Federal Trade Commission released an interim report charging that the middlemen marked up drugs ...
In late December, President-elect Donald Trump put pharmacy benefit managers ... Warren and activist regulators at Joe Biden’s Federal Trade Commission, which dropped a report just days before ...
In 2021, the FDA approved a new insulin drug, Semglee, that was interchangeable with a brand-name insulin called Lantus.